Obtenga las últimas noticias sobre las acciones de Legend Biotech con actualizaciones sobre las tendencias del mercado, las finanzas y el análisis de Benzinga. Manténgase informado sobre el rendimiento de LEGN

Últimas noticias sobre

LEGEND BIOTECH CORP-ADR

Legend Biotech

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

Legend Biotech Corporation - American Depositary Shares

Legend Biotech Corp

Earnings

Press Releases

Legend Biotech Reports First Quarter 2025 Results and Recent Highlights

News

Health Care

Legend Biotech to Host Investor Event During the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

Legend Biotech Announces New Oncologic & Hematologic Therapeutic Developments at ASCO, EHA, and ASGCT

Legend Biotech Unveils Groundbreaking 5-Year Survival Data for CARVYKTI® in Multiple Myeloma at 2025 ASCO Annual Meeting

Legend Biotech to Host Investor Conference Call on Second Quarter 2025 Results

Legend Biotech Reports Second Quarter 2025 Results and Recent Highlights

Management

Legend Biotech Appoints Carlos Santos as Chief Financial Officer

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

NanoViricides Reports NV-387's Anti-Inflammatory Effects Could Combat Viral-Induced Cancer Resurgence

SynOx Therapeutics Strengthens Board of Directors with Leading Experts in Commercialisation and Corporate Development Amid Continued Corporate Progress

AKRO

EXEL

LEGN

NNVC

REGN

VKTX

Abivax

Arcellx

Akero Therapeutics

Alkermes

Arrowhead Pharmaceuticals, Inc. - Common Stock

Arrowhead Pharma

Caris Life Sciences

CRISPR Therapeutics

Cytokinetics, Incorporated - Common Stock

Cytokinetics

Exelixis

Grifols, S.A. - American Depositary Shares

Grifols

Halozyme Therapeutics, Inc. - Common Stock

Halozyme Therapeutics

Krystal Biotech

Kymera Therapeutics

Madrigal Pharmaceuticals, Inc. - Common Stock

Madrigal Pharmaceuticals

Jyong Biotech

Merus

Metsera

NewAmsterdam Pharma Company N.V. - Ordinary Shares

NewAmsterdam Pharma Co

Nuvalent

Vaxcyte

PTC Therapeutics

Protagonist Therapeutics, Inc. - Common Stock

Protagonist Therapeutics

Avidity Biosciences

Rhythm Pharmaceuticals, Inc. - Common Stock

Rhythm Pharmaceuticals

TG Therapeutics

HC Wainwright & Co.

JP Morgan

Cantor Fitzgerald

RBC Capital

Morgan Stanley

Comments

Legend Biotech Noticias bursátiles

Noticias

Últimas noticias sobre

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL